Medicinal chemistry insights into novel CDC25 inhibitors

被引:20
作者
Tao, Yucen [1 ]
Hao, Xia [1 ]
Ding, Xiao [1 ]
Cherukupalli, Srinivasulu [1 ]
Song, Yuning [2 ]
Liu, Xinyong [1 ]
Zhan, Peng [1 ]
机构
[1] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Key Lab Chem Biol,Minist Educ, 44 West Culture Rd, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Dept Clin Pharm, Qilu Hosp, Jinan 250012, Peoples R China
基金
中国国家自然科学基金;
关键词
Cancer; Cell-cycle; CDC25; phosphatases; Inhibitor; Drug discovery; CELL-CYCLE CONTROL; BIOLOGICAL EVALUATION; PHOSPHATASE INHIBITORS; COUMARIN DERIVATIVES; CHALCONE DERIVATIVES; MOLECULAR DOCKING; CRYSTAL-STRUCTURE; CLICK-CHEMISTRY; DRUG DISCOVERY; IN-VITRO;
D O I
10.1016/j.ejmech.2020.112374
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cell division cycle 25 (CDC25) phosphatases, a kind of cell cycle regulators, have become an attractive target for drug discovery, as they have been found to be over-expressed in various human cancer cells. Several CDC25 inhibitors have achieved significant attention in clinical trials with possible mechanistic actions. Prompted by the significance of CDC25 inhibitors with medicinal chemistry prospect, it is an apt time to review the various drug discovery methods involved in CDC25 drug discovery including high throughput screening (HTS), virtual screening (VS), fragment-based drug design, substitution decorating approach, structural simplification approach and scaffold hopping method to seek trends and identify promising new avenues of CDC25 drug discovery. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:14
相关论文
共 106 条
[21]  
[Anonymous], 2016, CELL PHYSIOL BIOCHEM, DOI DOI 10.1159/000445652
[22]  
[Anonymous], 2015, MOL CARCINOGEN, DOI DOI 10.1002/MC.22094
[23]  
[Anonymous], 2008, J MED CHEM, DOI DOI 10.1021/JM701157G
[24]  
[Anonymous], 2019, FITOTERAPIA, DOI DOI 10.1016/J.FITOTE.2018.12.017
[25]  
[Anonymous], 2011, ORG BIOMOL CHEM, DOI DOI 10.1039/C1OB06150J
[26]  
[Anonymous], 2010, BIOORG MED CHEM LETT, DOI DOI 10.1016/J.BMCL.2010.07.130
[27]  
[Anonymous], 2015, ACS CHEM BIOL, DOI DOI 10.1021/CB500883H
[28]  
[Anonymous], 2009, BIOORG MED CHEM LETT, DOI DOI 10.1016/J.BMCL.2009.05.078
[29]  
[Anonymous], 2014, PHARMACOL REP, DOI DOI 10.1016/J.PHAREP.2013.08.016
[30]  
[Anonymous], 2007, BIOCHEMISTRY US, DOI DOI 10.1021/BI700026J